Syra Health Corp. Class A Common Stock (SYRA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Syra Health Corp. Class A Common Stock (SYRA) is up 496.1% since the beginning of the year. At $1 per share, SYRA is trading 27.1% below its 52-week high of $1.

Syra Health Corp. Class A Common Stock (SYRA) has returned 496.14% so far this year and 473.03% over the past 12 months.

Based on dividend-adjusted daily data since Sep 29, 2023, SYRA's average daily return is +0.67%, while the average monthly return is +2.60%. At this rate, an investment would double in approximately 2.3 years.

Historically, 36% of months were positive and 64% were negative. The best month was Apr 2026 with a return of +127.6%, while the worst month was Apr 2025 at -62.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, SYRA closed higher 41% of trading days. The best single day was Feb 8, 2024 with a return of +336.6%, while the worst single day was Apr 21, 2025 at -47.3%.

Syra Health Corp. Class A Common Stock has an annualized alpha of 328.82%, beta of 1.00, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 02, 2023.

• This stock participated in 362.87% of S&P 500 Index downside but only -0.30% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SYRA ranks 92 for risk / return — in the top 92% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Syra Health Corp. Class A Common Stock (SYRA) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Syra Health Corp. Class A Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Syra Health Corp. Class A Common Stock was 98.93%, occurring on Apr 23, 2025. The portfolio has not yet recovered.

The current Syra Health Corp. Class A Common Stock drawdown is 89.48%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Syra Health Corp. Class A Common Stock over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Syra Health Corp. Class A Common Stock is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.